RNA-binding protein 38 (RBM38) was originally recognized as an oncogene and it was frequently found to be amplified in prostate, ovarian and colorectal cancer, chronic lymphocytic leukemia, colon carcinoma, esophageal cancer, dog lymphomas and breast cancer (Ding et al., 2015). This evidence concerns the gene RBM38 and breast carcinoma.